Invitrall
Founded 2024 · 4 employees on LinkedIn · 1 known investors
Find your way into Invitrall
5 people in our graph share verified history with the Invitrall team — schools, employers, funds. One of them is your warm intro.
Gabriel Mantovani Bottosunlockedknows Gabriel Lohn Costa · together at Vesper Ventures (overlapped)
×2knows the team · via Vesper Ventures
×2knows the team · via Universidade Federal de Santa Catarina
Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
Founders & leadership
GL
Gabriel Lohn CostainCEOCEO of Invitrall, which develops human skin organoids from reprogrammed cells for pharmaceutical and cosmetics testing.
VC
Viviana Costa GagosiaCSO
Investors · 1
Frequently asked questions
- What does Invitrall do?
- Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.
- Who are Invitrall's investors?
- Invitrall's investors include GRIDX.